Aurinia completes follow-on

Autoimmune company Aurinia Pharmaceuticals Inc. (TSX:AUP; NASDAQ:AUPH) raised $150.5 million through the sale of 22.3 million shares at $6.75 in a follow-on underwritten by Leerink and Cantor Fitzger...